» Articles » PMID: 35243452

Is There an Association Between Lumbosacral Epidural Lipomatosis and Lumbosacral Epidural Steroid Injections? A Comprehensive Narrative Literature Review

Overview
Date 2022 Mar 4
PMID 35243452
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Exogenous systemic steroid exposure is a well-established risk factor for spinal epidural lipomatosis (SEL), however the association between lumbosacral epidural steroid injections (LESIs) and lumbosacral epidural lipomatosis (LEL) is generally regarded as poorly understood. Our objective was to investigate the rationale and the evidence implicating LESI(s) as a potential cause of LEL as well as the evidence related to use of LESI(s) as a potential pain relieving treatment option for radicular pain in the setting of LEL.

Methods: PubMed, Embase, Google Scholar, OVID were searched from inception until April 2021. Three investigators identified literature that provided original descriptive patient clinical data attributing the development/progression of LEL to LESI(s) or described the use of LESI(s) as a pain relieving modality for radicular pain in the setting of LEL.

Results: Fourteen publications were included for review. Overall, the current level of evidence is of low-quality. There are significant methodological gaps on this subject matter and many studies do not account for confounding variables independently associated with LEL.

Conclusions: This review has identified substantial limitations in the literature regarding that which is truly known regarding LESI(s) and LEL, as well as conservative management overall. To provide a well-rounded perspective, we synthesized literature as it pertains to: 1) current knowledge regarding SEL, notable associations and potential implications for corticosteroid exposure; 2) corticosteroid exposure and lipoatrophy; 3) current management recommendations for SEL and 4) areas for future focus. Although LESI(s) have been associated with LEL in the literature, presently due to a lack of rigorous, high-quality studies, the presence or absence of an independent causal relationship between LESI(s) and LEL cannot be stated with confidence.

Citing Articles

FACTFINDERS for PATIENT SAFETY: Preventing procedure-related complications: Epidural lipomatosis and postpartum steroid exposure.

DSouza R, Zheng P, Christolias G, Holder E, Lee H, Miller D Interv Pain Med. 2024; 3(2):100408.

PMID: 39238584 PMC: 11372935. DOI: 10.1016/j.inpm.2024.100408.


Chiropractic management of lumbar spinal epidural lipomatosis in a U.S. Veterans Affairs clinic: a report of two cases.

Pham A, Price M J Can Chiropr Assoc. 2024; 68(1):49-57.

PMID: 38840968 PMC: 11149685.


[Clinical research progress of spinal epidural lipomatosis].

Zhang L, Xu Y, Fan P, Li X, Wang J, Tao Y Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023; 37(10):1284-1291.

PMID: 37848326 PMC: 10581873. DOI: 10.7507/1002-1892.202305071.

References
1.
Pace C, Blanchet N, Isaacs J . Soft Tissue Atrophy Related to Corticosteroid Injection: Review of the Literature and Implications for Hand Surgeons. J Hand Surg Am. 2018; 43(6):558-563. DOI: 10.1016/j.jhsa.2018.03.004. View

2.
Kakourou T, Dacou-Voutetakis C, Kavadias G, Bakoula C, Aroni K . Limited joint mobility and lipodystrophy in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Dermatol. 1994; 11(4):310-4. DOI: 10.1111/j.1525-1470.1994.tb00094.x. View

3.
Mehta P, Syrop I, Singh J, Kirschner J . Systematic Review of the Efficacy of Particulate Versus Nonparticulate Corticosteroids in Epidural Injections. PM R. 2016; 9(5):502-512. DOI: 10.1016/j.pmrj.2016.11.008. View

4.
Mozumdar A, Liguori G . Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care. 2010; 34(1):216-9. PMC: 3005489. DOI: 10.2337/dc10-0879. View

5.
Underwood L, Voina S, Van Wyk J . Restoration of growth by human growth hormone (Roos) in hypopituitary dwarfs immunized by other human growth hormone preparations: clinical and immunological studies. J Clin Endocrinol Metab. 1974; 38(2):288-97. DOI: 10.1210/jcem-38-2-288. View